Guidelines

P1.10 Lactic acidosis as an atypical presentation of a diffuse large B-cell lymphoma

January 2015
P1.11 Primary Cutaneous T-cell Lymphoproliferative Disorders Expressing a CD8 and CD30-Positive Phenotype

January 2015
P1.12 Tumor lysis syndrome: monocentric evaluation of a predictive tool

January 2015
P1.13 Temsirolimus in daily clinical practice: results from the Belgian mantle cell lymphoma registry

January 2015
P1.14 Monoclonal B-cell lymphocytosis (MBL): results of a routine screening in a general hospital

January 2015
P1.15 Outcome after salvage chemotherapy with DHAP/ICE-type regimens and attempt to transplant in patients with aggressive lymphoma: experience of a single centre

January 2015
P1.16 Monoclonal B-cell lymphocytosis (MBL): results olmpact of extracellular vesicles from mesenchymal stromal cells-based microenvironment on Chronic Lymphocytic Leukemia B-cells

January 2015
P1.17 DNA hydroxymethylation in chronic lymphocytic leukemia: TET and IDH mRNA expression, prognostic significance and influence of microenvironment

January 2015
P1.18 Monoclonal B-cell lymphocytosis with a lymphoma phenotype: characterization and prognosis of a patient cohort

January 2015
P1.19 The role of the Anaphase Promoting Complex/ Cyclosome in multiple myeloma cell growth

January 2015

Top